REDWOOD CITY, Calif.--(BUSINESS WIRE)--InterVene, Inc., a clinical-stage medical device company dedicated to developing interventional solutions for chronic venous insufficiency (CVI), announced today ...
The first patient has been treated with InterVene’s Recana thrombectomy system for restoring patency (blood flow) in chronically obstructed deep veins and venous stents. The US-based clinical stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback